Net Loss of Bharat Parenterals reported to Rs 4.39 crore in the quarter ended December 2025 as against net loss of Rs 1.67 crore during the previous quarter ended December 2024. Sales declined 9.78% to Rs 65.19 crore in the quarter ended December 2025 as against Rs 72.26 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales65.1972.26 -10 OPM %2.675.04 - PBDT0.173.25 -95 PBT-8.28-5.50 -51 NP-4.39-1.67 -163 Powered by Capital Market - Live News

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 30 January 2026.Powered by Capital Market - Live News

Net Loss of Bharat Parenterals reported to Rs 7.24 crore in the quarter ended September 2025 as against net loss of Rs 7.50 crore during the previous quarter ended September 2024. Sales declined 9.79% to Rs 64.62 crore in the quarter ended September 2025 as against Rs 71.63 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales64.6271.63 -10 OPM %1.28-10.69 - PBDT1.25-6.36 LP PBT-7.31-15.37 52 NP-7.24-7.50 3 Powered by Capital Market - Live News

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Bharat Parenterals announced that the Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live News